Loading...
Loading...
India's plasma imports from INDONESIA total $138 across 1 shipments from 1 foreign suppliers. PT EQUILAB INTERNATIONAL leads with $138 in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include ADMERUS BIOSCIENCES PRIVATE LIMITED. This corridor reflects India's pharmaceutical import demand for plasma โ a concentrated sourcing relationship with select suppliers from INDONESIA.

PT EQUILAB INTERNATIONAL is the leading Plasma supplier from INDONESIA to India, with import value of $138 across 1 shipments. The top 5 suppliers โ PT EQUILAB INTERNATIONAL โ collectively account for 100.0% of total import value from this origin.
Ranked by import value (USD) ยท Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | PT EQUILAB INTERNATIONAL | $138 | 1 | 100.0% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | ADMERUS BIOSCIENCES PRIVATE LIMITED | $138 | 1 | 100.0% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Plasma suppliers from INDONESIA to India include PT EQUILAB INTERNATIONAL. The leading supplier is PT EQUILAB INTERNATIONAL with import value of $138 USD across 1 shipments. India imported Plasma worth $138 USD from INDONESIA in total across 1 shipments.
India imported Plasma worth $138 USD from INDONESIA across 1 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Plasma sourced from INDONESIA include ADMERUS BIOSCIENCES PRIVATE LIMITED. The largest buyer is ADMERUS BIOSCIENCES PRIVATE LIMITED with $138 in imports across 1 shipments.
The total value of Plasma imports from INDONESIA to India is $138 USD, across 1 shipments and 1 foreign suppliers. Data source: Indian Customs (DGFT).
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records โ the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
1 Verified Shipments
1 suppliers, 1 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists